Skip to content

Drug interactions

Tocilizumab + Ustekinumab

Severity: Major

Tocilizumab and Ustekinumab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Two biologic immunomodulators acting on different cytokine pathways may add to the risk of serious infections, including tuberculosis and opportunistic infections. Combined use of biologics is not well studied and is generally not recommended.

What this interaction means in plain words

Tocilizumab and Ustekinumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Tocilizumab belongs to Musculoskeletal; Ustekinumab belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Additive immunosuppression through IL-12/23 blockade and IL-6 receptor blockade.

What to do

Avoid concurrent use of the two biologics; if switching, monitor for infection during the transition. Screen for latent tuberculosis before therapy.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Tocilizumab and Ustekinumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Tocilizumab with Ustekinumab?

MediHelp rates the interaction as major. Tocilizumab and Ustekinumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Two biologic immunomodulators acting on different cytokine pathways may add to the risk of serious infections, including tuberculosis and opportunistic infections. Combined use of biologics is not well studied and is generally not recommended.

How serious is the interaction between Tocilizumab and Ustekinumab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use of the two biologics; if switching, monitor for infection during the transition. Screen for latent tuberculosis before therapy.

What other medicines interact with Ustekinumab?

MediHelp also lists interactions of Ustekinumab with, for example, Bcg vaccine live, Typhoid vaccine live, Adalimumab. The full list is on the Ustekinumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in